Carregant...
Metformin and LW6 impairs pancreatic cancer cells and reduces nuclear localization of YAP1
The poor survival rate of pancreatic cancer is still a major challenge for the clinicians and their patients. In this study, we evaluated the efficacy of metformin, an inhibitor of oxidative phosphorylation, in combination with LW6, which impairs malate dehydrogenase 2 activities, in treating pancre...
Guardat en:
| Publicat a: | J Cancer |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6930432/ https://ncbi.nlm.nih.gov/pubmed/31897243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.33029 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|